Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1969 2
1971 3
1972 2
1973 6
1974 5
1975 7
1976 10
1977 13
1978 10
1979 10
1980 10
1981 13
1982 11
1983 17
1984 19
1985 20
1986 16
1987 21
1988 21
1989 17
1990 39
1991 23
1992 22
1993 21
1994 35
1995 37
1996 39
1997 31
1998 40
1999 47
2000 43
2001 45
2002 34
2003 50
2004 41
2005 55
2006 64
2007 52
2008 57
2009 67
2010 71
2011 65
2012 60
2013 68
2014 72
2015 71
2016 77
2017 67
2018 64
2019 67
2020 83
2021 63
2022 56
2023 58
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

1,866 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Childhood Malignant Central Nervous System Neoplasm"
Page 1
Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety.
Vitanza NA, Wilson AL, Huang W, Seidel K, Brown C, Gustafson JA, Yokoyama JK, Johnson AJ, Baxter BA, Koning RW, Reid AN, Meechan M, Biery MC, Myers C, Rawlings-Rhea SD, Albert CM, Browd SR, Hauptman JS, Lee A, Ojemann JG, Berens ME, Dun MD, Foster JB, Crotty EE, Leary SES, Cole BL, Perez FA, Wright JN, Orentas RJ, Chour T, Newell EW, Whiteaker JR, Zhao L, Paulovich AG, Pinto N, Gust J, Gardner RA, Jensen MC, Park JR. Vitanza NA, et al. Cancer Discov. 2023 Jan 9;13(1):114-131. doi: 10.1158/2159-8290.CD-22-0750. Cancer Discov. 2023. PMID: 36259971 Free PMC article.
Diffuse intrinsic pontine glioma (DIPG) remains a fatal brainstem tumor demanding innovative therapies. As B7-H3 (CD276) is expressed on central nervous system (CNS) tumors, we designed B7-H3-specific chimeric antigen receptor (CAR) T cells, confirmed their p …
Diffuse intrinsic pontine glioma (DIPG) remains a fatal brainstem tumor demanding innovative therapies. As B7-H3 (CD276) is expressed on …
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Goldman S, Pollack IF, Qaddoumi I, Jakacki RI, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Jones DTW, Pfister SM, Vezina G, Stern JS, Panigrahy A, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M. Fangusaro J, et al. Lancet Oncol. 2019 Jul;20(7):1011-1022. doi: 10.1016/S1470-2045(19)30277-3. Epub 2019 May 28. Lancet Oncol. 2019. PMID: 31151904 Free PMC article. Clinical Trial.
BACKGROUND: Paediatric low-grade glioma is the most common CNS tumour of childhood. Although overall survival is good, disease often recurs. ...This trial is registered with ClinicalTrials.gov, number NCT01089101. ...
BACKGROUND: Paediatric low-grade glioma is the most common CNS tumour of childhood. Although overall survival is good, disease often …
Craniopharyngioma.
Müller HL. Müller HL. Handb Clin Neurol. 2014;124:235-53. doi: 10.1016/B978-0-444-59602-4.00016-2. Handb Clin Neurol. 2014. PMID: 25248591 Review.
Because irradiation is efficient in preventing tumor progression, appropriate timing of postsurgical irradiation is currently under investigation in the randomized multinational trial KRANIOPHARYNGEOM 2007 that analyzes quality of life as primary endpoint. Childh …
Because irradiation is efficient in preventing tumor progression, appropriate timing of postsurgical irradiation is currently under investig …
Craniopharyngioma.
Müller HL. Müller HL. Endocr Rev. 2014 Jun;35(3):513-43. doi: 10.1210/er.2013-1115. Epub 2014 Jan 27. Endocr Rev. 2014. PMID: 24467716 Review.
Clinical manifestations are related to hypothalamic/pituitary deficiencies, visual impairment, and increased intracranial pressure. ...Irradiation has proven effective in reducing recurrences and progression, and timing of postsurgical irradiation in childhood-onset …
Clinical manifestations are related to hypothalamic/pituitary deficiencies, visual impairment, and increased intracranial pressure. . …
Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16.
Jeha S, Pei D, Choi J, Cheng C, Sandlund JT, Coustan-Smith E, Campana D, Inaba H, Rubnitz JE, Ribeiro RC, Gruber TA, Raimondi SC, Khan RB, Yang JJ, Mullighan CG, Downing JR, Evans WE, Relling MV, Pui CH. Jeha S, et al. J Clin Oncol. 2019 Dec 10;37(35):3377-3391. doi: 10.1200/JCO.19.01692. Epub 2019 Oct 28. J Clin Oncol. 2019. PMID: 31657981 Free PMC article. Clinical Trial.
PATIENTS AND METHODS: Between 2007 and 2017, 598 consecutive patients age 0 to 18 years received risk-directed chemotherapy without prophylactic cranial irradiation in the St Jude Total Therapy Study 16. Patients were randomly assigned to receive PEG-asparaginase 3,500 U/m …
PATIENTS AND METHODS: Between 2007 and 2017, 598 consecutive patients age 0 to 18 years received risk-directed chemotherapy without prophyla …
Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data.
Crotty EE, Wilson AL, Davidson T, Tahiri S, Gust J, Griesinger AM, Venkataraman S, Park JR, Mueller S, Rood BR, Hwang EI, Wang LD, Vitanza NA. Crotty EE, et al. Curr Oncol Rep. 2023 Aug;25(8):847-855. doi: 10.1007/s11912-023-01423-3. Epub 2023 May 9. Curr Oncol Rep. 2023. PMID: 37160547 Free PMC article. Review.
PURPOSE OF REVIEW: Correlative studies should leverage clinical trial frameworks to conduct biospecimen analyses that provide insight into the bioactivity of the intervention and facilitate iteration toward future trials that further improve patient outcomes. ...Her …
PURPOSE OF REVIEW: Correlative studies should leverage clinical trial frameworks to conduct biospecimen analyses that provide …
Radiation-induced meningioma.
Umansky F, Shoshan Y, Rosenthal G, Fraifeld S, Spektor S. Umansky F, et al. Neurosurg Focus. 2008;24(5):E7. doi: 10.3171/FOC/2008/24/5/E7. Neurosurg Focus. 2008. PMID: 18447746 Review.
The long-term or delayed side effects of irradiation on neural tissue are now known to include the induction of new central nervous system neoplasms. However, during the first half of the 20th century, human neural tissue was generally considered relat …
The long-term or delayed side effects of irradiation on neural tissue are now known to include the induction of new central nervou …
Central nervous system lymphoma.
Lister A, Abrey LE, Sandlund JT. Lister A, et al. Hematology Am Soc Hematol Educ Program. 2002:283-96. doi: 10.1182/asheducation-2002.1.283. Hematology Am Soc Hematol Educ Program. 2002. PMID: 12446428 Review.
Central nervous system involvement with malignant lymphoma whether primary or secondary is an uncommon but not rare complication observed in the management of patients with hematological malignancy. ...In Section II, Dr. John Sandlund reviews th …
Central nervous system involvement with malignant lymphoma whether primary or secondary is an uncommon but not r …
Early and late endocrine effects in pediatric central nervous system diseases.
Aslan IR, Cheung CC. Aslan IR, et al. J Pediatr Rehabil Med. 2014;7(4):281-94. doi: 10.3233/PRM-140299. J Pediatr Rehabil Med. 2014. PMID: 25547881 Review.
Endocrinopathies are frequently linked to central nervous system disease, both as early effects prior to the disease diagnosis and/or late effects after the disease has been treated. ...Diagnosing and treating both early and late endocrine manifestations can …
Endocrinopathies are frequently linked to central nervous system disease, both as early effects prior to the disease di …
Medulloblastoma and central nervous system germ cell tumors in adults: is pediatric experience applicable?
Mascarin M, Coassin E, Franceschi E, Gandola L, Carrabba G, Brandes AA, Massimino M. Mascarin M, et al. Childs Nerv Syst. 2019 Dec;35(12):2279-2287. doi: 10.1007/s00381-019-04340-8. Epub 2019 Aug 14. Childs Nerv Syst. 2019. PMID: 31414168 Review.
Medulloblastoma and central nervous system (CNS) germ cell tumors are very rare in adults, while they account for 25% and 5% of brain tumors in children, respectively (Pastore et al. Eur J Cancer 42:2064-208, 2006). Pediatric experiences, mostly from rando …
Medulloblastoma and central nervous system (CNS) germ cell tumors are very rare in adults, while they account for 25% a …
1,866 results